Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$41.79 USD
+2.26 (5.72%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $41.80 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: -- |
3/2024 | $-2.12 | -12.80% |
Earnings Summary
For their last quarter, Rhythm Pharmaceuticals (RYTM) reported earnings of -$0.70 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RYTM's next earnings release expected on May 07, 2024. For the next earning release, we expect the company to report earnings of -$2.12 per share, reflecting a year-over-year decrease of 130.43%.
Earnings History
Price & Consensus
Zacks News for RYTM
Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline
RYTM: What are Zacks experts saying now?
Zacks Private Portfolio Services